Welcome to the 2022 IGCS Meeting Program Scheduling
The Meeting will officially run on US Eastern Time (ETD/GMT-4)
To check the meeting times to your local time Click Here
Session Description:
This GSK-sponsored symposium will explore the progress made in biomarker-driven care for patients with ovarian or endometrial cancer. Our knowledgeable faculty will review how understanding has evolved around molecular targets in these diseases, and how this information guides treatment selection and influences patient outcomes. In turn, the speakers will discuss the current options for biomarker-directed therapy, before giving their perspectives on the key clinical biomarkers that may inform the future standard of care for these gynecological malignancies.
Session Description:
The management for patients whom platinum base therapy is no longer an option is challenging. The purpose of this symposium review current treatment options and future strategies for overcoming PARP resistance and helping patients find opportunities beyond platinum therapy.
This expert panel will:
- Defining platinum-based therapy that is no longer an option for patients
- Impact of prior therapies
* MOA and definition on PARP Resistance
* Strategies for overcoming PARP resistance
* Impact of PARP Inhibitors on subsequent therapies
- Outlining new novel strategies
- Defining new, exciting trials in these populations
Session Description:
This interactive symposium will focus on the changes occurring for the treatment the endometrial cancer patient. It will be cased based on presentations with robust panel discussions and the use of audience polling to guide the discussions.